66 varieties cancel the medical insurance code, 37 varieties suspend online purchases

On February 28, the Shanghai Pharmaceutical Sunshine Purchasing Network issued a new announcement.
In order to further standardize the "sunshine procurement" management of Chinese herbal decoction pieces, the city's pharmacy office took action to rectify the varieties of Chinese medicine decoction pieces
.
According to the list of annexes, the medical insurance codes of 66 varieties (82 specifications) such as snake gallbladder, chrysanthemum root, Luo Hanguo, and agarwood are to be cancelled, and 37 such as bear bile powder, wolfberry leaf, rush charcoal, forest ginseng, cordyceps sinensis, and bezoar are suspended.
Sunshine purchasing qualification for varieties (42 product gauges)
.

 

This "one stop and one cancellation" has created thousands of waves in the Chinese medicine decoction pieces industry.
Combined with the "Notice on Carrying out the Pilot Work of the Clinical Application of the Whole Process Traceability of Chinese Medicine Decoction Pieces in the City" issued by Shanghai a few days ago, there are already 5 well-known Chinese medicine hospitals And 8 pharmaceutical companies use traceable decoction pieces as a pilot, and encourage high quality and good prices, and further increase the remediation of Chinese medicine decoction pieces
.

 

Strict risk control, high quality and high price

 

Structural adjustment of Chinese herbal decoction pieces

 

According to the 2021 version of the medical insurance drug catalog, a total of 892 kinds of Chinese herbal medicines can be paid by the medical insurance fund
.
In the section of decoction pieces, those that cannot be included in the scope of the fund payment include: donkey-hide gelatin, cordyceps sinensis, velvet antler, musk, American ginseng and wild ginseng, etc.
The decoction pieces that Shanghai has suspended procurement of include varieties in this range
.

 

　　In fact, on February 11, the State Food and Drug Administration held a video conference on the in-depth development of the national drug safety special rectification action work.
A unified deployment has been made across the country.
In response to the strong complaints from the people in the fields of drugs, medical equipment and cosmetics , we will crack down on them.
Focus on the production and sale of counterfeit and inferior medicines, illegal production of Chinese herbal decoction pieces, and illegal online sales, strictly prevent and strictly control quality and safety risks, and focus on in-depth special rectification of drug
safety .

 

　　Decoction pieces of traditional Chinese medicine have always been the focus of attention of all parties
.
The Beijing Municipal Food and Drug Administration has further strengthened the supervision of traditional Chinese medicine preparations and Chinese medicine decoction pieces; in 2021, Gansu Province will supervise and inspect the coverage of Chinese medicine decoction pieces and preparation production enterprises to 100%, and the rectification efforts will be further strengthened
.
In addition, medical insurance has formed a synergy with the regulatory authorities in the access link
.
In 2020, the National Medical Insurance Bureau issued the "Notice on Printing and Distributing the Uniform Coding Rules and Methods of Chinese Medicine Pieces of Medical Insurance Drugs and Preparations of Medical Institutions"
.
For example, starting from February 26, all Chinese herbal decoction pieces and formula granules used by all public medical institutions in Beijing will be purchased online
.
At the same time, the advantages of the unified coding and information coordination of the medical insurance information platform are used to provide an important starting point for the work related to the medical insurance field such as the fight against fraud and insurance fraud
.

 

　　

 

　　Through comprehensive rectification, industry reshuffle must be the general trend
.
In the past ten years, the registered volume of domestic Chinese herbal decoction pieces companies has grown rapidly and developed rapidly.
There are tens of thousands of registered companies involved in the Chinese herbal medicine decoction pieces business, but there will be a significant decrease in 2021, and the overall trend will be declining
.
It can be speculated that there will be more small and medium-sized decoction pieces factories in the future
.

 

　　On a deeper level, as the rectification work of the decoction piece industry continues to advance, how to make the decoction pieces high quality and good price has become a new hot spot
.
In addition to Shanghai, the Zhejiang Provincial Medical Insurance Bureau recently planned to explore the formation mechanism of high-quality and high-price Chinese medicines
.
However, experts believe, "Because the processing of decoction pieces is time-consuming and costly, plus there are many varieties of Chinese herbal medicines, there are many complicated inspection items, and many Chinese herbal medicines are large in size, prone to insects and mildew, and high logistics and transportation costs.
Occupying the market and forming a pricing mechanism for decoction pieces is not an easy task, and there is still a long way to go
.
”

 

　　Crisis coexist? Mixed joy?

 

　　The era of quality competition of decoction pieces is coming

 

　　With the support of national systemic policies, traditional Chinese medicine and decoction pieces have ushered in new opportunities.
However, the quality and safety of Chinese medicine decoction pieces has always been the focus of attention
.
The State Food and Drug Administration recently issued a notice on the "Guiding Opinions on the Principles of Application of Paragraph 2 of Article 117 of the Drug Administration Law", clarifying that the decoction pieces of traditional Chinese medicine to which this article applies are made from natural sources of plants, animals, and mineral medicinal materials.
Made
.
Considering the special nature of Chinese herbal medicines, special provisions are made on their relevant legal responsibilities: "Production and sales of Chinese herbal medicines that do not meet drug standards and do not affect safety and effectiveness are ordered to correct within a time limit, and given a warning; a fine of 100,000 yuan may be imposed.
A fine of not less than 500,000 yuan but not more than 500,000 yuan
.
” It is certain that the safety net of the supervision of Chinese herbal decoction pieces will become more and more dense
.
How to strengthen quality improvement is a question that many companies need to pay attention to
.

 

　　According to the "2020 Economic Operation Report of China's Pharmaceutical Industry", the market size of Chinese herbal medicine decoction pieces processing market in 2020 will reach 178.
2 billion yuan
.
However, the TCM decoction pieces industry presents common problems such as complex business differentiation, low industrial concentration, fierce competition, uneven quality of TCM decoction pieces, insufficient innovation in the industry, and ambiguous directions.
However, opportunities are always reserved for preparedness.
business
.
For high-quality brands, industrial structural adjustment is a new business opportunity
.

 

　　

 

　　According to the Minet database, in 2020, the sales of Chinese patent medicines in retail pharmacies will account for 28%, and the proportion in public medical institutions will be as high as 78%, and the sales in medical institutions will still account for the majority
.
In terms of traditional Chinese medicine decoction pieces, among the TOP20 products of traditional Chinese medicine decoction pieces in urban physical pharmacies, there are 11 products that belong to the medical insurance catalog
.
Among them, astragalus and wolfberry are large varieties with sales of over 1 billion yuan, and they are all tonics
.
The sales of red ginseng, chrysanthemum and other decoction pieces also exceeded 500 million yuan
.
If you zoom in to the national market, the scale is even more impressive
.

 

　　On the contrary, if the support of medical insurance is lost, many decoction pieces are bound to be affected
.
For example, in the first quarter of 2021, among the sales of Chinese herbal decoction pieces in Chinese urban physical pharmacies, Cordyceps sinensis rose well, with a year-on-year increase of more than 19.
90%
.
If such varieties with sales of more than 1 billion are suspended from purchase, many companies will still face the test
.
As a variety with sales of more than 2 billion, American ginseng has a growth rate of 5.
08%.
After the implementation of centralized procurement and other policies, it will test the company's supply chain cost capability and brand competitiveness, and a new challenge has begun
.

 

　　On February 28, the Shanghai Pharmaceutical Sunshine Purchasing Network issued a new announcement.
In order to further standardize the "sunshine procurement" management of Chinese herbal decoction pieces, the city's pharmacy office took action to rectify the varieties of Chinese medicine decoction pieces
.
According to the list of annexes, the medical insurance codes of 66 varieties (82 specifications) such as snake gallbladder, chrysanthemum root, Luo Hanguo, and agarwood are to be cancelled, and 37 such as bear bile powder, wolfberry leaf, rush charcoal, forest ginseng, cordyceps sinensis, and bezoar are suspended.
Sunshine purchasing qualification for varieties (42 product gauges)
.

 

　　This "one stop and one cancellation" has created thousands of waves in the Chinese medicine decoction pieces industry.
Combined with the "Notice on Carrying out the Pilot Work of the Clinical Application of the Whole Process Traceability of Chinese Medicine Decoction Pieces in the City" issued by Shanghai a few days ago, there are already 5 well-known Chinese medicine hospitals And 8 pharmaceutical companies use traceable decoction pieces as a pilot, and encourage high quality and good prices, and further increase the remediation of Chinese medicine decoction pieces
.

 

　　Strict risk control, high quality and high price

 

　　Structural adjustment of Chinese herbal decoction pieces

 

　　According to the 2021 version of the medical insurance drug catalog, a total of 892 kinds of Chinese herbal medicines can be paid by the medical insurance fund
.
In the section of decoction pieces, those that cannot be included in the scope of the fund payment include: donkey-hide gelatin, cordyceps sinensis, velvet antler, musk, American ginseng and wild ginseng, etc.
The decoction pieces that Shanghai has suspended procurement of include varieties in this range
.

 

　　In fact, on February 11, the State Food and Drug Administration held a video conference on the in-depth development of the national drug safety special rectification action work.
A unified deployment has been made across the country.
In response to the strong complaints from the people in the fields of drugs, medical equipment and cosmetics , we will crack down on them.
Focus on the production and sale of counterfeit and inferior medicines, illegal production of Chinese herbal decoction pieces, and illegal online sales, strictly prevent and strictly control quality and safety risks, and focus on in-depth special rectification of drug
safety .

 

　　Decoction pieces of traditional Chinese medicine have always been the focus of attention of all parties
.
The Beijing Municipal Food and Drug Administration has further strengthened the supervision of traditional Chinese medicine preparations and Chinese medicine decoction pieces; in 2021, Gansu Province will supervise and inspect the coverage of Chinese medicine decoction pieces and preparation production enterprises to 100%, and the rectification efforts will be further strengthened
.
In addition, medical insurance has formed a synergy with the regulatory authorities in the access link
.
In 2020, the National Medical Insurance Bureau issued the "Notice on Printing and Distributing the Uniform Coding Rules and Methods of Chinese Medicine Pieces of Medical Insurance Drugs and Preparations of Medical Institutions"
.
For example, starting from February 26, all Chinese herbal decoction pieces and formula granules used by all public medical institutions in Beijing will be purchased online
.
At the same time, the advantages of the unified coding and information coordination of the medical insurance information platform are used to provide an important starting point for the work related to the medical insurance field such as the fight against fraud and insurance fraud
.

 

　　

 

　　Through comprehensive rectification, industry reshuffle must be the general trend
.
In the past ten years, the registered volume of domestic Chinese herbal decoction pieces companies has grown rapidly and developed rapidly.
There are tens of thousands of registered companies involved in the Chinese herbal medicine decoction pieces business, but there will be a significant decrease in 2021, and the overall trend will be declining
.
It can be speculated that there will be more small and medium-sized decoction pieces factories in the future
.

 

　　On a deeper level, as the rectification work of the decoction piece industry continues to advance, how to make the decoction pieces high quality and good price has become a new hot spot
.
In addition to Shanghai, the Zhejiang Provincial Medical Insurance Bureau recently planned to explore the formation mechanism of high-quality and high-price Chinese medicines
.
However, experts believe, "Because the processing of decoction pieces is time-consuming and costly, plus there are many varieties of Chinese herbal medicines, there are many complicated inspection items, and many Chinese herbal medicines are large in size, prone to insects and mildew, and high logistics and transportation costs.
Occupying the market and forming a pricing mechanism for decoction pieces is not an easy task, and there is still a long way to go
.
”

 

　　Crisis coexist? Mixed joy?

 

　　The era of quality competition of decoction pieces is coming

 

　　With the support of national systemic policies, traditional Chinese medicine and decoction pieces have ushered in new opportunities.
However, the quality and safety of Chinese medicine decoction pieces has always been the focus of attention
.
The State Food and Drug Administration recently issued a notice on the "Guiding Opinions on the Principles of Application of Paragraph 2 of Article 117 of the Drug Administration Law", clarifying that the decoction pieces of traditional Chinese medicine to which this article applies are made from natural sources of plants, animals, and mineral medicinal materials.
Made
.
Considering the special nature of Chinese herbal medicines, special provisions are made on their relevant legal responsibilities: "Production and sales of Chinese herbal medicines that do not meet drug standards and do not affect safety and effectiveness are ordered to correct within a time limit, and given a warning; a fine of 100,000 yuan may be imposed.
A fine of not less than 500,000 yuan but not more than 500,000 yuan
.
” It is certain that the safety net of the supervision of Chinese herbal decoction pieces will become more and more dense
.
How to strengthen quality improvement is a question that many companies need to pay attention to
.

 

　　According to the "2020 Economic Operation Report of China's Pharmaceutical Industry", the market size of Chinese herbal medicine decoction pieces processing market in 2020 will reach 178.
2 billion yuan
.
However, the TCM decoction pieces industry presents common problems such as complex business differentiation, low industrial concentration, fierce competition, uneven quality of TCM decoction pieces, insufficient innovation in the industry, and ambiguous directions.
However, opportunities are always reserved for preparedness.
business
.
For high-quality brands, industrial structural adjustment is a new business opportunity
.

 

　　

 

　　According to the Minet database, in 2020, the sales of Chinese patent medicines in retail pharmacies will account for 28%, and the proportion in public medical institutions will be as high as 78%, and the sales in medical institutions will still account for the majority
.
In terms of traditional Chinese medicine decoction pieces, among the TOP20 products of traditional Chinese medicine decoction pieces in urban physical pharmacies, there are 11 products that belong to the medical insurance catalog
.
Among them, astragalus and wolfberry are large varieties with sales of over 1 billion yuan, and they are all tonics
.
The sales of red ginseng, chrysanthemum and other decoction pieces also exceeded 500 million yuan
.
If you zoom in to the national market, the scale is even more impressive
.

 

　　On the contrary, if the support of medical insurance is lost, many decoction pieces are bound to be affected
.
For example, in the first quarter of 2021, among the sales of Chinese herbal decoction pieces in Chinese urban physical pharmacies, Cordyceps sinensis rose well, with a year-on-year increase of more than 19.
90%
.
If such varieties with sales of more than 1 billion are suspended from purchase, many companies will still face the test
.
As a variety with sales of more than 2 billion, American ginseng has a growth rate of 5.
08%.
After the implementation of centralized procurement and other policies, it will test the company's supply chain cost capability and brand competitiveness, and a new challenge has begun
.